55,159 Shares of UnitedHealth Group Incorporated $UNH Purchased by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the third quarter, Holdings Channel reports. The firm bought 55,159 shares of the healthcare conglomerate’s stock, valued at approximately $20,248,000.

Several other institutional investors also recently bought and sold shares of UNH. BlackRock Inc. boosted its position in UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after purchasing an additional 3,395,530 shares in the last quarter. State Street Corp increased its holdings in shares of UnitedHealth Group by 0.7% during the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock valued at $18,966,555,000 after purchasing an additional 301,081 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of UnitedHealth Group by 6.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock valued at $4,449,317,000 after purchasing an additional 616,723 shares in the last quarter. Wellington Management Group LLP lifted its stake in shares of UnitedHealth Group by 5.8% in the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate’s stock valued at $4,436,923,000 after purchasing an additional 583,536 shares during the period. Finally, Corient Private Wealth LP boosted its holdings in UnitedHealth Group by 1,443.7% during the second quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate’s stock worth $3,510,920,000 after buying an additional 7,900,011 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

UNH opened at $403.14 on Thursday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The company has a market cap of $361.22 billion, a price-to-earnings ratio of 23.02, a PEG ratio of 1.47 and a beta of 0.51. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62. The firm’s fifty day simple moving average is $391.12 and its two-hundred day simple moving average is $364.76.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. During the same quarter in the previous year, the company earned $2.59 earnings per share. The company’s quarterly revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be paid a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s payout ratio is 53.00%.

Analyst Ratings Changes

A number of research firms have weighed in on UNH. Raymond James Financial reaffirmed an “outperform” rating and issued a $450.00 price objective on shares of UnitedHealth Group in a report on Thursday, October 15th. UBS Group restated an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, October 13th. Sanford C. Bernstein cut their price target on UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating for the company in a research note on Wednesday, October 14th. HC Wainwright set a $500.00 price target on UnitedHealth Group in a report on Friday, October 16th. Finally, Deutsche Bank increased their price target on UnitedHealth Group from $370.00 to $467.00 and gave the stock a “hold” rating in a research report on Friday, July 17th. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $463.93.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.19% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.